- Home
- ALNY vs PCG Comparison
ALNY vs PCG Comparison
Compare ALNY & PCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- PCG
- Stock Information
- Founded
- ALNY 2002
- PCG 1905
- Country
- ALNY United States
- PCG United States
- Employees
- ALNY N/A
- PCG N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- PCG Power Generation
- Sector
- ALNY Health Care
- PCG Utilities
- Exchange
- ALNY Nasdaq
- PCG Nasdaq
- Market Cap
- ALNY 42.9B
- PCG 30.0B
- IPO Year
- ALNY 2004
- PCG N/A
- Fundamental
- Price
- ALNY $343.69
- PCG $14.12
- Analyst Decision
- ALNY Strong Buy
- PCG Buy
- Analyst Count
- ALNY 25
- PCG 13
- Target Price
- ALNY $347.75
- PCG $20.65
- AVG Volume (30 Days)
- ALNY 869.5K
- PCG 22.7M
- Earning Date
- ALNY 07-31-2025
- PCG 07-31-2025
- Dividend Yield
- ALNY N/A
- PCG 0.71%
- EPS Growth
- ALNY N/A
- PCG N/A
- EPS
- ALNY N/A
- PCG 1.09
- Revenue
- ALNY $2,348,099,000.00
- PCG $24,541,000,000.00
- Revenue This Year
- ALNY $32.73
- PCG $6.29
- Revenue Next Year
- ALNY $31.50
- PCG $3.08
- P/E Ratio
- ALNY N/A
- PCG $12.84
- Revenue Growth
- ALNY 17.21
- PCG 1.91
- 52 Week Low
- ALNY $205.87
- PCG $12.97
- 52 Week High
- ALNY $333.70
- PCG $21.72
- Technical
- Relative Strength Index (RSI)
- ALNY 64.89
- PCG 52.79
- Support Level
- ALNY $323.74
- PCG $13.85
- Resistance Level
- ALNY $332.19
- PCG $14.27
- Average True Range (ATR)
- ALNY 7.50
- PCG 0.26
- MACD
- ALNY 0.31
- PCG 0.16
- Stochastic Oscillator
- ALNY 94.08
- PCG 84.62
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About PCG Pacific Gas & Electric Co.
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision between January 2019 and June 2020. In 2004, PG&E sold its unregulated assets as part of an earlier postbankruptcy reorganization.